The following resources and publications are available from the ACT Consortium:


a. Safety data collection tools for real-world reporting (French version also available here.)

b. Safety webinar


c. Safety animation:


d. ACTc Publications relating to safety methods:

'How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials'

'Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data'

'Designing adverse event forms for real-world reporting: Participatory research in Uganda'

'Eliciting harms data from trial participants: how perceptions of illness and treatment mediate recognition of relevant information to report'

'Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients'

'The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients'   

'“Every drug goes to treat its own disease…” - A qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania'

'Neuroauditory toxicity of artemisinin combination therapies—Have safety concerns been addressed?'

''… in the project they really care for us': meaning and experiences of participating in a clinical study of first-line treatment for malaria and HIV in Tanzanian adults'

e. Quality Outputs:

'Degradation of Artemisinin-Based Combination Therapies Under Tropical Conditions'

'Fake anti-malarials: start with the facts'

'Quality of artemisinin-based combination formulations for Malaria treatment: Prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria'

'Quality of artemisinin-containing antimalarials in Tanzania’s private sector— Results from a nationally representative outlet survey'

'Quality of antimalarials at the epicenter of antimalarial drug resistance: Results from an overt and mystery client survey in Cambodia'

'Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa'

Poor quality vital anti-malarials in Africa - an urgent neglected public health priority

'Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries'

'Antimalarial drug quality: methods to detect suspect drugs'